{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-318488","form_type":"8-K","ticker":"SPRB","cik":"0001683553","company_name":"SPRUCE BIOSCIENCES, INC.","filed_at":"2025-12-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.141414+00:00","generated_at":"2026-05-16T13:13:56.613111+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Spruce Biosciences appoints Keli Walbert to Board of Directors","bullets":["Keli Walbert appointed as Class I Director effective December 11, 2025, term expiring at 2027 annual meeting.","Granted nonstatutory stock option to purchase 3,400 shares vesting monthly over three years.","Annual cash retainer: $40,000 as director; $5,000 for Compensation Committee (increasing to $5,500 in 2026).","Eligible for annual option grant of 1,700 shares starting with 2026 annual meeting, vesting over one year.","Entered into standard indemnification agreement; no related-party transactions disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-318488","json":"https://secwatch.observer/filing/0001193125-25-318488.json","markdown":"https://secwatch.observer/filing/0001193125-25-318488.md","text":"https://secwatch.observer/filing/0001193125-25-318488.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1683553/000119312525318488/0001193125-25-318488-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1683553/000119312525318488/sprb-20251211.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:13:56.613111+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}